ClinicalTrials.gov record
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
ClinicalTrials.gov ID: NCT00042289
Public ClinicalTrials.gov record NCT00042289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum
Study identification
- NCT ID
- NCT00042289
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 1,578 participants
Conditions and interventions
Conditions
Interventions
- TAF w/cobicistat Drug
- TAF w/cobicistat or ritonavir Drug
- abacavir Drug
- amikacin Drug
- amprenavir Drug
- atazanavir/cobicistat Drug
- atazanavir/ritonavir dosage #1 Drug
- atazanavir/ritonavir dosage #2 Drug
- atazanavir/ritonavir/tenofovir dosage #1 Drug
- bedaquiline Drug
- capreomycin Drug
- clofazamine Drug
- darunavir/cobicistat Drug
- darunavir/ritonavir dosage #1 Drug
- darunavir/ritonavir dosage #2 Drug
- darunavir/ritonavir dosage #3 Drug
- darunavir/ritonavir dosage #4 Drug
- delamanid Drug
- didanosine delayed release (Videx® EC) Drug
- dolutegravir Drug
- efavirenz Drug
- elvitegravir/cobicistat Drug
- emtricitabine Drug
- ethambutol Drug
- ethinyl estradiol Drug
- ethionamide/prothionamide Drug
- etonogestrel implant Drug
- etravirine Drug
- fosamprenavir/ritonavir Drug
- high dose INH Drug
- indinavir/ritonavir dosage #1 Drug
- indinavir/ritonavir dosage #2 Drug
- isoniazid Drug
- kanamycin Drug
- levoflaxacin Drug
- linezolid Drug
- lopinavir/ritonavir dosage #1 Drug
- lopinavir/ritonavir dosage #2 Drug
- lopinavir/ritonavir dosage #3 Drug
- lopinavir/ritonavir dosage #4 Drug
- maraviroc Drug
- moxifloxacin Drug
- nelfinavir dosage #1 Drug
- nelfinavir dosage #2 Drug
- nevirapine Drug
- ofloxacin Drug
- para-aminosalicylic acid (PAS) Drug
- pretomanid Drug
- pyrazinamide Drug
- raltegravir Drug
- rifampicin Drug
- rilpivirine Drug
- tenofovir Drug
- tenofovir alafenamide fumarate (TAF) Drug
- tenofovir/atazanavir/ritonavir dosage #2 Drug
- terizidone/cycloserine Drug
- tipranavir/ritonavir Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2003
- Primary completion
- Sep 29, 2020
- Completion
- Sep 29, 2020
- Last update posted
- Dec 1, 2025
2003 – 2020
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Pediatric Infectious Diseases CRS | Birmingham | Alabama | 35233 | — |
| University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program | La Jolla | California | 92093-0672 | — |
| Miller Children's Hosp. Long Beach CA NICHD CRS | Long Beach | California | 90806 | — |
| Usc La Nichd Crs | Los Angeles | California | 90089 | — |
| David Geffen School of Medicine at UCLA NICHD CRS | Los Angeles | California | 90095-1752 | — |
| Univ. of California San Francisco NICHD CRS | San Francisco | California | 94143 | — |
| Harbor UCLA Medical Ctr. NICHD CRS | Torrance | California | 90502 | — |
| Univ. of Colorado Denver NICHD CRS | Aurora | Colorado | 80045 | — |
| Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease | New Haven | Connecticut | 06510 | — |
| Washington Hosp. Ctr. NICHD CRS | Washington D.C. | District of Columbia | 20010 | — |
| Univ. of Florida Jacksonville NICHD CRS | Jacksonville | Florida | 32209 | — |
| Pediatric Perinatal HIV Clinical Trials Unit CRS | Miami | Florida | 33136 | — |
| USF - Tampa NICHD CRS | Tampa | Florida | 33606 | — |
| Emory University School of Medicine NICHD CRS | Atlanta | Georgia | 30322 | — |
| Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases | Augusta | Georgia | 30912 | — |
| Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program | Chicago | Illinois | 60608 | — |
| Rush Univ. Cook County Hosp. Chicago NICHD CRS | Chicago | Illinois | 60612 | — |
| Univ. of Illinois College of Medicine at Chicago, Dept. of Peds. | Chicago | Illinois | 60612 | — |
| Lurie Children's Hospital of Chicago (LCH) CRS | Chicago | Illinois | 60614-3393 | — |
| Tulane Univ. New Orleans NICHD CRS | New Orleans | Louisiana | 70112 | — |
| Univ. of Maryland Baltimore NICHD CRS | Baltimore | Maryland | 21201 | — |
| Johns Hopkins Univ. Baltimore NICHD CRS | Baltimore | Maryland | 21287 | — |
| Children's Hosp. of Boston NICHD CRS | Boston | Massachusetts | 02115 | — |
| Boston Medical Center Ped. HIV Program NICHD CRS | Boston | Massachusetts | 02118 | — |
| Baystate Health, Baystate Med. Ctr. | Springfield | Massachusetts | 01199 | — |
| WNE Maternal Pediatric Adolescent AIDS CRS | Worcester | Massachusetts | 01605 | — |
| Children's Hospital of Michigan NICHD CRS | Detroit | Michigan | 48201 | — |
| Rutgers - New Jersey Medical School CRS | Newark | New Jersey | 07103 | — |
| Nyu Ny Nichd Crs | New York | New York | 10016 | — |
| Metropolitan Hosp. NICHD CRS | New York | New York | 10029 | — |
| Columbia IMPAACT CRS | New York | New York | 10032 | — |
| SUNY Stony Brook NICHD CRS | Stony Brook | New York | 11794 | — |
| Bronx-Lebanon Hospital Center NICHD CRS | The Bronx | New York | 10457 | — |
| Jacobi Med. Ctr. Bronx NICHD CRS | The Bronx | New York | 10461 | — |
| DUMC Ped. CRS | Durham | North Carolina | 27710 | — |
| Philadelphia IMPAACT Unit CRS | Philadelphia | Pennsylvania | 19104 | — |
| Regional Med. Ctr. at Memphis | Memphis | Tennessee | 38103 | — |
| St. Jude Children's Research Hospital CRS | Memphis | Tennessee | 38105-3678 | — |
| Seattle Children's Research Institute CRS | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00042289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00042289 live on ClinicalTrials.gov.